Send us a text

The FDA has granted full approval to Novavax's COVID-19 vaccine, providing an alternative to mRNA vaccines that works through a different mechanism using proteins and adjuvants. Despite being four years into the pandemic, COVID-19 remains a significant health concern, causing approximately 1 in 200 deaths in the US in 2025.

• Novavax uses bioengineered spike proteins combined with an adjuvant rather than mRNA technology
• FDA approved Novavax for all Americans over 65 and those 12-64 with at least one risk factor
• Risk factors include conditions like asthma, diabetes, and obesity
• Northeast Florida contributed 500 patients to the original Novavax clinical trials
• Encore Research Group is currently enrolling participants for an oral COVID vaccine clinical trial
• Participants in the oral vaccine trial will receive compensation for their time

For more information about participating in the oral COVID vaccine study, visit EncoreDocs.com or call 904-730-0101.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!